Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Debt Ratio: 2020-2022

Historic Debt Ratio for RedHill Biopharma (RDHL) over the last 3 years, with Dec 2022 value amounting to 0.73.

  • RedHill Biopharma's Debt Ratio rose 57.14% to 0.73 in Q4 2022 from the same period last year, while for Dec 2022 it was 0.73, marking a year-over-year increase of 57.14%. This contributed to the annual value of 0.73 for FY2022, which is 57.14% up from last year.
  • Per RedHill Biopharma's latest filing, its Debt Ratio stood at 0.73 for FY2022, which was up 57.14% from 0.46 recorded in FY2021.
  • RedHill Biopharma's 5-year Debt Ratio high stood at 0.73 for FY2022, and its period low was 0.45 during FY2020.
  • Over the past 3 years, RedHill Biopharma's median Debt Ratio value was 0.46 (recorded in 2021), while the average stood at 0.55.
  • Data for RedHill Biopharma's Debt Ratio shows a peak YoY spiked of 57.14% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows RedHill Biopharma's Debt Ratio stood at 0.45 in 2020, then increased by 2.21% to 0.46 in 2021, then soared by 57.14% to 0.73 in 2022.